Spatially resolved transcriptomics and its applications in cancer

Nuclei Detection for 3D Microscopy With a Fully Convolutional Regression Network

Advances in three-dimensional microscopy and tissue clearing are enabling whole-organ imaging with single-cell resolution. Fast and reliable image processing tools are needed to analyze the resulting image volumes, including automated cell detection, cell counting and cell analytics. Deep learning approaches have shown promising results in two- and three-dimensional nuclei detection tasks, however detecting overlapping or non-spherical nuclei of different sizes and shapes in the presence of a blurring point spread function remains challenging and often leads to incorrect nuclei merging and splitting. Here we present a new regression-based fully convolutional network that located a thousand nuclei centroids with high accuracy in under a minute when combined with V-net, a popular three-dimensional semantic-segmentation architecture. High nuclei detection F1-scores of 95.3% and 92.5% were obtained in two different whole quail embryonic hearts, a tissue type difficult to segment because of its high cell density, and heterogeneous and elliptical nuclei. Similar high scores were obtained in the mouse brain stem, demonstrating that this approach is highly transferable to nuclei of different shapes and intensities. Finally, spatial statistics were performed on the resulting centroids. The spatial distribution of nuclei obtained by our approach most resembles the spatial distribution of manually identified nuclei, indicating that this approach could serve in future spatial analyses of cell organization.

Spatial profiling technologies and applications for brain cancers

INTRODUCTION

Malignant primary and secondary brain tumors pose a major health challenge, and the incidence of these tumors is rising. The brain tumor microenvironment (TME) is highly complex and thought to impact treatment resistance and failure. To enable a greater understanding of the milieu of cells in the brain TME, advances in imaging and sequential profiling of proteins/mRNA have given rise to the field of spatial transcriptomics. These technologies provide a greater depth of understanding of the tissue architecture, cellular and spatial profiles, including cellular activation status, which may provide insights into effective therapies for brain cancers.

AREAS COVERED

In this review, we provide an overview of spatial profiling technologies at the forefront in the field and describe the applications for brain cancer.

EXPERT OPINION

Brain tumors are often resistant to treatment, and display both an immunosuppressive and heterogeneous tumor microenvironment. Next-generation imaging and multi-omics technologies are providing a tool for intricately characterizing their tissue biology. This information will aid in the design of effective therapies and begin to provide an understanding of therapy resistance.